Definium Therapeutics, Inc. Announces Closing of $805 Million Upsized Public Offering, Including Full Exercise of the Underwriters’ Option to Purchase Additional Shares

Go back to Definium Therapeutics, Inc. Announces Closing of $805 Million Upsized Public Offering, Including Full Exercise of the Underwriters’ Option to Purchase Additional Shares
(NASDAQ: DFTX) Delayed: 38.09 --0 (-0%)
Previous Close $38.09    52 Week High
Open $38.09    52 Week Low
Day High $38.09    P/E N/A 
Day Low $38.09    EPS
Volume 15,104